Filtros

Buscador
Año
Nadarajah R, Ludman P, Laroche C, Appelman Y, Brugaletta S, Budaj A, Bueno H, Huber K, Kunadian V, Leonardi S, Lettino M, Milasinovic D, Gale CP; NSTEMI investigator group. Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology. Eur Heart J Qual Care Clin Outcomes. 2023 Sep 12;9(6):552-563. doi: 10.1093/ehjqcco/qcad008. PubMed PMID: 36737420; PubMed Central PMCID: PMC10495699.
AÑO: 2023; IF: 4.8
Esteve-Pastor MA, Soler-Espejo E, Marin F. Reticulated Platelets: A Promising Prognosis Marker in Cardiovascular Diseases. Thromb Haemost. 2024 Apr;124(4):320-323. doi: 10.1055/a-2170-1892. Epub 2023 Sep 7. No abstract available. PubMed PMID: 37678557.
AÑO: 2024; IF: 4.3
Masana L, Diaz Moya G, Perez de Isla L; HEARTBEAT study investigators. Patients who suffer a first atherosclerotic cardiovascular event while taking statins are often far off of lipid targets. Nutr Metab Cardiovasc Dis. 2024 Jan;34(1):90-97. doi: 10.1016/j.numecd.2023.09.022. Epub 2023 Oct 11. PubMed PMID: 38092606.
AÑO: 2024; IF: 3.7
Anguita-Gamez M, Vivas D, Ferrandis R, Esteve-Pastor MA, Marin F, Anguita Sanchez M; REQXAA study investigators. Periprocedural use of antithrombotic therapy in interventional cardiology in Spain: are we doing better than other specialties? Rev Esp Cardiol (Engl Ed). 2024 Aug;77(8):701-703. doi: 10.1016/j.rec.2024.02.017. Epub 2024 Apr 3. No abstract available. English, Spanish. PubMed PMID: 38580142.
AÑO: 2024; IF: 4.9
Lopez-Galvez R, Rivera-Caravaca JM, Mandaglio-Collados D, Ruiz-Alcaraz AJ, Lahoz-Tornos A, Hernandez-Romero D, Orenes-Pinero E, Ramos-Bratos MP, Martinez CM, Carpes M, Arribas-Leal JM, Canovas S, Lip GYH, Marin F. Endothelial activation, Cell-Cell Interactions, and Inflammatory Pathways in Postoperative Atrial Fibrillation Following Cardiac Surgery. Biomed J. 2024 Nov 25:100821. doi: 10.1016/j.bj.2024.100821. Online ahead of print. PubMed PMID: 39603594.
AÑO: 2024; IF: 4.4